Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Modelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa.

Abuelezam NN, McCormick AW, Surface ED, Fussell T, Freedberg KA, Lipsitch M, Seage GR.

Epidemiol Infect. 2019 Jan;147:e122. doi: 10.1017/S0950268818003497.

PMID:
30869008
2.

Cost of an HIV Medical Care Coordination Program in Los Angeles County.

Schackman BR, Jeng PJ, Flash MJE, Mejia M, Oksuzyan S, Scott JA, Freedberg KA, Kulkarni SP, Garland WH.

J Acquir Immune Defic Syndr. 2019 Feb 21. doi: 10.1097/QAI.0000000000001994. [Epub ahead of print] No abstract available.

PMID:
30865169
3.

Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.

Frank SC, Cohn J, Dunning L, Sacks E, Walensky RP, Mukherjee S, Dugdale CM, Turunga E, Freedberg KA, Ciaranello AL.

Lancet HIV. 2019 Mar;6(3):e182-e190. doi: 10.1016/S2352-3018(18)30328-X. Epub 2019 Feb 5.

PMID:
30737187
4.

Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.

Chen Q, Larochelle MR, Weaver DT, Lietz AP, Mueller PP, Mercaldo S, Wakeman SE, Freedberg KA, Raphel TJ, Knudsen AB, Pandharipande PV, Chhatwal J.

JAMA Netw Open. 2019 Feb 1;2(2):e187621. doi: 10.1001/jamanetworkopen.2018.7621.

5.

Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.

Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR Jr, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RP.

Lancet Glob Health. 2019 Feb;7(2):e200-e208. doi: 10.1016/S2214-109X(18)30436-4.

6.

Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort.

Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, Drain PK.

BMC Infect Dis. 2019 Jan 5;19(1):14. doi: 10.1186/s12879-018-3614-7.

7.

HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?

Neilan AM, Cohn JE, Lemaire JF, Sacks E, Alban R, Freedberg KA, Walensky RP, Ciaranello AL.

Open Forum Infect Dis. 2018 Aug 29;5(8):ofy170. doi: 10.1093/ofid/ofy170. eCollection 2018 Aug.

8.

Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.

Luong Nguyen LB, Yazdanpanah Y, Maman D, Wanjala S, Vandenbulcke A, Price J, Parker RA, Hennequin W, Mendiharat P, Freedberg KA.

Clin Infect Dis. 2018 Aug 16;67(5):719-726. doi: 10.1093/cid/ciy173.

9.

Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk.

Mallampati D, MacLean RL, Shapiro R, Dabis F, Engelsmann B, Freedberg KA, Leroy V, Lockman S, Walensky R, Rollins N, Ciaranello A.

J Int AIDS Soc. 2018 Apr;21(4):e25107. doi: 10.1002/jia2.25107.

10.

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.

Freedberg KA, Kumarasamy N, Borre ED, Ross EL, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RP.

AIDS Res Hum Retroviruses. 2018 Jun;34(6):486-497. doi: 10.1089/AID.2017.0258. Epub 2018 May 3.

11.

The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.

Luz PM, Osher B, Grinsztejn B, Maclean RL, Losina E, Stern ME, Struchiner CJ, Parker RA, Freedberg KA, Mesquita F, Walensky RP, Veloso VG, Paltiel AD.

J Int AIDS Soc. 2018 Mar;21(3):e25096. doi: 10.1002/jia2.25096.

12.

The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.

Zheng A, Kumarasamy N, Huang M, Paltiel AD, Mayer KH, Rewari BB, Walensky RP, Freedberg KA.

J Int AIDS Soc. 2018 Mar;21(3):e25085. doi: 10.1002/jia2.25085.

13.

High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian Cohort.

Ahonkhai AA, Banigbe B, Adeola J, Bassett IV, Idigbe I, Okonkwo P, Freedberg KA, Regan S, Losina E.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):322-328. doi: 10.1097/QAI.0000000000001670.

PMID:
29533304
14.

The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV.

Neilan AM, Dunville R, Ocfemia MCB, Salomon JA, Francke JA, Bulteel AJB, Wang LY, Hsu KK, DiNenno EA, Walensky RP, Parker RA, Freedberg KA, Ciaranello AL.

J Adolesc Health. 2018 Jan;62(1):22-28. doi: 10.1016/j.jadohealth.2017.08.028.

15.

Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.

Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP.

Health Aff (Millwood). 2017 Dec;36(12):2142-2150. doi: 10.1377/hlthaff.2017.0684.

16.

The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.

Dunning L, Francke JA, Mallampati D, MacLean RL, Penazzato M, Hou T, Myer L, Abrams EJ, Walensky RP, Leroy V, Freedberg KA, Ciaranello A.

PLoS Med. 2017 Nov 21;14(11):e1002446. doi: 10.1371/journal.pmed.1002446. eCollection 2017 Nov.

17.

Using Observational Data to Calibrate Simulation Models.

Murray EJ, Robins JM, Seage GR 3rd, Lodi S, Hyle EP, Reddy KP, Freedberg KA, HernĂ¡n MA.

Med Decis Making. 2018 Feb;38(2):212-224. doi: 10.1177/0272989X17738753. Epub 2017 Nov 15.

18.

The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.

Borre ED, Hyle EP, Paltiel AD, Neilan AM, Sax PE, Freedberg KA, Weinstein MC, Walensky RP.

J Infect Dis. 2017 Oct 17;216(7):798-807. doi: 10.1093/infdis/jix349.

19.

The patient-centered medical home: a reality for HIV care in Nigeria.

Ahonkhai AA, Onwuatuelo I, Regan S, Adegoke A, Losina E, Banigbe B, Adeola J, Ferris TG, Okonkwo P, Freedberg KA.

Int J Qual Health Care. 2017 Oct 1;29(5):654-661. doi: 10.1093/intqhc/mzx083.

20.

Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa.

Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Freedberg KA, Bassett IV.

Open Forum Infect Dis. 2017 Aug 14;4(3):ofx167. doi: 10.1093/ofid/ofx167. eCollection 2017 Summer.

Supplemental Content

Loading ...
Support Center